跳至主要内容
临床试验/CTIS2024-515850-26-00
CTIS2024-515850-26-00招募中1 期

PET-DOPA Metabolic Detection and Characterization of Untreated Brain Metastases of Bronchial, Breast and Melanoma Cancer (DOPACER) - ICO-202-28 DOPACER

Institut De Cancerologie De L Ouest0 个研究点目标入组 52 人开始时间: 2024年6月27日最近更新:

试验速览

阶段
1 期
状态
招募中
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Histologically proven primary cancer (non-small cell lung, breast or melanoma), 2) Presence of brain metastasis(s) visualized on MRI, with at least 1 measuring more than 5 mm, 3) Age = 18 years

排除标准

  • 1) History of cerebral irradiation, 2) Previous brain surgery for brain metastasis or glial tumor, 3) Systemic therapy (chemotherapy, targeted therapy, immunotherapy) modified in the 6 weeks preceding the PET-DOPA scan,, 4) New anti-tumor treatment (excluding corticosteroids) started between the discovery of CD and the performance of the PET-DOPA scan, 5) Other concomitant cancer, or history of cancer in the 5 years preceding the patient's inclusion in the protocol other than basal or squamous cell carcinoma, 6) Pregnant, likely to be pregnant or breastfeeding

研究者

相似试验

进行中(未招募)
1 期
PET-DOPA Metabolic Detection and Characterization of Untreated Brain Metastases of Bronchial, Breast and Melanoma Cancerpatients with newly discovered brain metastases (non-small cell lung cancer, breast cancer or melanoma) measuring more than 5 mm and explored on MRIMedDRA version: 20.0Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10027480Term: Metastatic malignant melanomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2021-001017-37-FRINSTITUT DE CANCEROLOGIE DE L'OUEST52
尚未招募
不适用
Biomarkers For Early Diagnosis Of Pre Diabetes In pancreatic Disease
CTRI/2020/02/023208Science and Engineering Research Board
招募中
3 期
Role of PET/CT scan to look for response of chemo and radiotherapy in esophageal cancer before surgeryPurpose of this study is to see whether PET/CT scan is useful to assess whether chemo and radiotherapy are working and the cancer is reducing or not
CTRI/2014/01/004276All India Institute of Medical Sciences New Delhi50
终止
1 期
Response Monitoring Trial in Patients With Suspected Recurrence of GlioblastomaGlioblastomaGliomaGlioblastoma Multiforme
NCT02176720The Methodist Hospital Research Institute31
尚未招募
不适用
Cellular Oxygen METabolism (COMET) measurements during cardiopulmonary bypassmitochondrial function during CPB10007593
NL-OMON46485Erasmus MC, Universitair Medisch Centrum Rotterdam37